Duration of the IgM response in women acquiring Toxoplasma gondii during pregnancy: Implications for clinical practice and cross-sectional incidence studies

Epidemiology and Infection

Volumn 132, Issue 3, 2004, Pages 541-548

  Gras, L ^a   Gilbert, R E ^a   Wallon, M ^b   Peyron, F ^b   Cortina Borja, M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b CROIX ROUSSE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PYRIMETHAMINE SULFADIAZINE;

AGGLUTINATION TEST; ANALYTIC METHOD; ARTICLE; CLINICAL PRACTICE; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; IMMUNOFLUORESCENCE TEST; INCIDENCE; MAJOR CLINICAL STUDY; PREDICTION; PREGNANCY; PREVALENCE; SEROLOGY; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ADULT; AGGLUTINATION TESTS; ANIMALS; CROSS-SECTIONAL STUDIES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOGLOBULIN M; IMMUNOSORBENT TECHNIQUES; INCIDENCE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TOXOPLASMA; TOXOPLASMOSIS;

EID: 2642559539     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268803001948     Document Type: Article

References (25)

1. Remington JS, McLeod R, Thulliez P, Desmonts G. Toxoplasmosis. In: Remington JS, Klein J, eds. Infectious diseases of the fetus and newborn infant. Philadelphia: W. B. Saunders, 2001: 205-346.
2. Cook AJ, Gilbert RE, Buffolano W, et al. Sources of toxoplasma infection in pregnant women: European multicentre case-control study. European Research Network on Congenital Toxoplasmosis. BMJ 2000; 321: 142-147.
3. Dunn D, Wallon M, Peyron F, Petersen E, Peckham CS, Gilbert RE. Mother to child transmission of toxoplasmosis: risk estimates for clinical counseling. Lancet 1999; 353: 1829-1833.
4. Joynson DHM, Guy EC. Laboratory diagnosis of toxoplasma infection. In: Joynson DHM, Wreghitt TG, eds. Toxoplasmosis: a comprehensive clinical guide. Cambridge: Cambridge University Press, 2001: 296-318.
5. Kaplan EH, Brookmeyer R. Snapshot estimators of recent HIV incidence rates. Oper Res 1999; 47: 29-37.
6. Ades AE. Methods for estimating the incidence of primary infection in pregnancy: a reappraisal of toxoplasmosis and cytomegalovirus data. Epidemiol Infect 1992; 108: 367-375.
7. Ades AE, Nokes DJ. Modeling age- and time-specific incidence from seroprevalence: toxoplasmosis. Am J Epidemiol 1993; 137: 1022-1034.
8. Nokes DJ, Forsgren M, Gille E, Ljungstrom I. Modelling toxoplasma incidence from longitudinal seroprevalence in Stockholm, Sweden. Parasitology 1993; 107: 33-40.
9. Jenum PA, Stray Pedersen B. Development of specific immunoglobulins G, M, and A following primary Toxoplasma gondii infection in pregnant women. J Clin Microbiol 1998; 36: 2907-2913.
10. Sulzer AJ, Franco EL, Takafuji E, Benenson M, Walls KW, Greenup RL. An oocyst-transmitted outbreak of toxoplasmosis: patterns of immunoglobulin G and M over one year. Am J Trop Med Hyg 1986; 35: 290-296.
11. Naot Y, Guptill DR, Remington JS. Duration of IgM antibodies to Toxoplasma gondii after acute acquired toxoplasmosis. J Infect Dis 1982; 145: 770.
12. Cozon G, Roure C, Lizard G, et al. An improved assay for the detection of Toxoplasma gondii antibodies in human serum by flow cytometry. Cytometry 1993; 14: 569-575.
13. Desmonts G, Naot Y, Remington JS. Immunoglobulin M-immunosorbent agglutination assay for diagnosis of infectious diseases: diagnosis of acute congenital and acquired Toxoplasma infections. J Clin Microbiol 1981; 14: 486-491.
14. Gilbert RE, Gras L, Wallon M, Peyron F, Ades AE, Dunn D. Effect of prenatal treatment on mother to child transmission of Toxoplasma gondii: a cohort study of 554 mother-child pairs in Lyon, France. Int J Epidemiol 2001; 30: 1303-1308.
15. Kim MY, De Gruttola VG, Lagakos SW. Analyzing doubly censored data with covariates, with application to AIDS. Biometrics 1993; 49: 13-22.
16. Pan W. A multiple imputation approach to regression analysis for doubly censored data with applications to AIDS studies. Biometrics 2001; 57: 1245-1250.
17. Tanner MA. Tools for statistical inference. New York: Springer-Verlag, 1993.
18. Joss AWL. Diagnosis. In: Ho-Yen DO, Joss AWL, eds. Human toxoplasmosis. Oxford, Oxford Medical Publications, 1992: 79-118.
19. Roberts CW, Walker W, Alexander J. Sex-associated hormones and immunity to protozoan parasites. Clin Microbiol Rev 2001; 14: 476-488.
20. Gay-Andrieu F, Cozon GJ, Ferrandiz J, Peyron F. Progesterone fails to modulate Toxoplasma gondii replication in the RAW 264.7 murine macrophage cell line. Parasite Immunol 2002; 24: 173-178.
21. Liesenfeld O, Nguyen TA, Pharke C, Suzuki Y. Importance of gender and sex hormones in regulation of susceptibility of the small intestine to peroral infection with Toxoplasma gondii tissue cysts. J Parasitol 2001; 87: 1491-1493.
22. Weinstock H, Dale M, Gwinn M, et al. HIV seroincidence among patients at clinics for sexually transmitted diseases in nine cities in the United States. J Acquir Immune Defic Syndr 2002; 29: 478-483.
23. Janssen RS, Satten GA, Stramer SL, et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 1998; 280: 42-48.
24. Allain J-P, Palmer CR, Pearson G. Epidemiological study of latent and recent infection by Toxoplasma gondii in pregnant women from a regional population in the UK. J Infect 1998; 36: 189-196.
25. Ancelle T, Goulet V, Tirard-Fleury V, et al. La Toxoplasmose chez la femme enceinte en France en 1995. Resultats d'une enquete nationale perinatale [Toxoplasmosis during pregnancy in France, 1995: results of a national survey]. Bull Epidemiol Hebd 1996; 51: 227-229.